We demonstrated the utility of tailored MR fingerprinting (TMRF) of pediatric patients with brain tumor to 1) differentiate tumor from healthy tissue using quantitative maps; 2) tailor TMRF sequence to include T2 fluid-attenuated inversion recovery (FLAIR) contrast that could potentially substitute T2 FLAIR sequence used in routine pediatric tumor protocol. The mean土SD difference in T1 and T2 values between tumor and normal tissues for 3 patients were 1.05土0.09 and 0.05土0.02 seconds respectively. The TR and flip angle trains were tailored to include T2 FLAIR contrast for adult imaging. Current and future work includes optimizing T2 FLAIR for the pediatric population.
This abstract and the presentation materials are available to members only; a login is required.